Can't Miss Webinar—Lupus Nephritis: The ACR Guideline in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: fever

The Mystery of IVIg

Eveline Wu, MD, Michael M. Frank, MD  |  March 8, 2012

Although initially given as replacement therapy for patients with primary and secondary immunodeficiency states, intravenous immunoglobulin (IVIg) has proven to be effective in the treatment of various autoimmune and inflammatory disorders. This success has led to a dramatic increase in the use of IVIg, with its use as an antiinflammatory agent now vastly surpassing its use in the treatment of immunodeficiencies. Even so, the basis for the antiinflammatory activity of IVIg remains unclear.

Filed under:ConditionsOther Rheumatic Conditions Tagged with:anti-inflammatorydrugHYDROXYCHLOROQUINEimmunodeficiencyinflammationintravenous immune globulinMethotrexatemyalgiapatient carePediatricsrheumatologistTreatment

Susac’s Syndrome: Confusion, Expressive Aphasia, Gait Instability

Candace H. Feldman, MD, MPH, Gwendolyn Kane-Wagner, MD  |  March 8, 2012

A 49-year-old man presented to the hospital with confusion, dysarthria, expressive aphasia, and progressive gait instability.

Filed under:Career DevelopmentConditionsEducation & TrainingOther Rheumatic ConditionsProfessional Topics Tagged with:ANA titerDiagnostic Criteriadrugimagingintravenous immunoglobulinsPathogenesispatient careprednisonerheumatologistTreatment

Dermatology Case Answer

Joseph F. Merola, MD  |  February 3, 2012

A 64-year-old man with history of type-II diabetes (well controlled on sitagliptin/metformin), hypertension, and dyslipidemia presents with complaints of an increasingly painful left lower-extremity lesion present for two to three months.

Filed under:ConditionsSystemic Sclerosis Tagged with:DermatologyLipodermatosclerosisPainpatient carerheumatologistSclerodermaSystemic sclerosis

Coding Corner: February’s Coding Challenge

Staff  |  February 3, 2012

A 62-year-old male patient returns to the office for a followup visit for his gout.

Filed under:Billing/CodingConditionsGout and Crystalline ArthritisPractice Support Tagged with:BillingCancerCodingcrystal arthritisE&MGoutlabsPractice Managementrheumatologist

A Short History of Rheumatoid Arthritis Therapeutics

Simon M. Helfgott, MD  |  January 13, 2012

Or, why I chose to become a rheumatologist

Filed under:Biologics/DMARDsConditionsDrug UpdatesOpinionProfilesResearch RheumRheumatoid ArthritisRheuminationsSpeak Out Rheum Tagged with:BiologicsdrugEducationHelfgottMethotrexateprednisoneProfileResearchresidencyRheumatoid arthritisrheumatologist

A Walk in the Windy City

David S. Pisetsky, MD, PhD  |  December 12, 2011

A final column full of many thanks and a few parting thoughts

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:AC&Rrheumatologist

Coding Corner Question

Staff  |  December 12, 2011

December’s Coding Challenge

Filed under:Axial SpondyloarthritisBilling/CodingPractice Support Tagged with:Ankylosing SpondylitisBillingCodingPractice Management

Coding Corner Question

Staff  |  November 1, 2011

Skilled nursing facility patients

Filed under:Billing/CodingPractice Support Tagged with:BillingCodingGastritisRheumatoid arthritisSkilled nursing facility

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  November 1, 2011

Information on new approvals and medication safety

Filed under:Drug Updates Tagged with:anti-inflammatoryApprovalsAutoimmuneDrugsFDAPipelineSafetytumor necrosis factor

Coding Corner Question

Staff  |  October 7, 2011

October’s Coding Challenge Medically Unlikely Edits (MUE)

Filed under:Billing/CodingPractice Support Tagged with:BillingCodingPractice ManagementRARheumatoid arthritis

  • « Previous Page
  • 1
  • …
  • 45
  • 46
  • 47
  • 48
  • 49
  • …
  • 55
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences